Teva Motions Denied In Patent Spat With Pfizer
In a positive development for Pfizer Inc., Teva Pharmaceuticals Inc.'s pleas to exclude evidence and testimony in its patent dispute over the arthritis painkiller Celebrex were mostly denied by a federal...To view the full article, register now.
Already a subscriber? Click here to view full article